SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'NXU'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GHM_A_CEDA1_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	6 / 12	SER A 682 LYS A 685 SER A 737 ASN A 739 LYS A 890 GLY A 892	NXU A1001 (-1.3A) NXU A1001 ( 4.2A) NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-3.5A) NXU A1001 (-3.4A)	0.40A	1ghmA-4ra7A: 15.3	1ghmA-4ra7A: 20.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1GHM_A_CEDA1_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	6 / 12	SER A 682 LYS A 685 TYR A 720 SER A 737 LYS A 890 GLY A 892	NXU A1001 (-1.3A) NXU A1001 ( 4.2A) NXU A1001 (-4.1A) NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-3.4A)	0.87A	1ghmA-4ra7A: 15.3	1ghmA-4ra7A: 20.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1I2W_A_CFXA1300_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	7 / 12	SER A 682 LYS A 685 SER A 737 ASN A 739 THR A 876 LYS A 890 GLY A 892	NXU A1001 (-1.3A) NXU A1001 ( 4.2A) NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-4.0A) NXU A1001 (-3.5A) NXU A1001 (-3.4A)	0.49A	1i2wA-4ra7A: 15.7	1i2wA-4ra7A: 22.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1I2W_B_CFXB2300_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	6 / 12	SER A 682 LYS A 685 SER A 737 ASN A 739 THR A 876 GLY A 892	NXU A1001 (-1.3A) NXU A1001 ( 4.2A) NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-4.0A) NXU A1001 (-3.4A)	0.54A	1i2wB-4ra7A: 15.8	1i2wB-4ra7A: 22.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1YMX_A_CFXA1001_1 (BETA-LACTAMASE CTX-M-9)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	8 / 12	SER A 682 LYS A 685 SER A 737 ASN A 739 THR A 876 LYS A 890 GLY A 892 ASP A 895	NXU A1001 (-1.3A) NXU A1001 ( 4.2A) NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-4.0A) NXU A1001 (-3.5A) NXU A1001 (-3.4A) NXU A1001 (-3.1A)	0.70A	1ymxA-4ra7A: 16.8	1ymxA-4ra7A: 22.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1YMX_B_CFXB1002_1 (BETA-LACTAMASE CTX-M-9)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	7 / 12	SER A 682 LYS A 685 SER A 737 ASN A 739 LYS A 890 GLY A 892 ASP A 895	NXU A1001 (-1.3A) NXU A1001 ( 4.2A) NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-3.5A) NXU A1001 (-3.4A) NXU A1001 (-3.1A)	0.61A	1ymxB-4ra7A: 16.4	1ymxB-4ra7A: 22.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HLW_A_CE3A301_1 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	6 / 12	LYS A 685 SER A 737 ASN A 739 THR A 876 LYS A 890 GLY A 892	NXU A1001 ( 4.2A) NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-4.0A) NXU A1001 (-3.5A) NXU A1001 (-3.4A)	0.49A	3hlwA-4ra7A: 16.8	3hlwA-4ra7A: 22.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HLW_B_CE3B302_1 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	6 / 12	SER A 737 ASN A 739 THR A 876 LYS A 890 THR A 891 GLY A 892	NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-4.0A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A)	0.38A	3hlwB-4ra7A: 17.0	3hlwB-4ra7A: 22.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HUO_A_PNNA300_0 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	6 / 12	LYS A 685 ASN A 739 LYS A 890 THR A 891 GLY A 892 ASP A 895	NXU A1001 ( 4.2A) NXU A1001 (-3.5A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A) NXU A1001 (-3.1A)	0.57A	3huoA-4ra7A: 16.8	3huoA-4ra7A: 22.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3HUO_B_PNNB301_0 (CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	5 / 12	LYS A 685 ASN A 739 LYS A 890 GLY A 892 ASP A 895	NXU A1001 ( 4.2A) NXU A1001 (-3.5A) NXU A1001 (-3.5A) NXU A1001 (-3.4A) NXU A1001 (-3.1A)	0.62A	3huoB-4ra7A: 16.7	3huoB-4ra7A: 22.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3NY4_A_SMXA308_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	8 / 12	SER A 682 SER A 737 THR A 876 LYS A 890 THR A 891 GLY A 892 THR A 893 ASP A 895	NXU A1001 (-1.3A) NXU A1001 (-3.2A) NXU A1001 (-4.0A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A) NXU A1001 (-3.9A) NXU A1001 (-3.1A)	0.66A	3ny4A-4ra7A: 16.3	3ny4A-4ra7A: 23.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3Q07_A_WPPA300_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	6 / 12	LYS A 685 SER A 737 ASN A 739 LYS A 890 GLY A 892 ASP A 895	NXU A1001 ( 4.2A) NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-3.5A) NXU A1001 (-3.4A) NXU A1001 (-3.1A)	0.58A	3q07A-4ra7A: 16.6	3q07A-4ra7A: 22.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3Q07_B_WPPB400_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	6 / 12	LYS A 685 SER A 737 ASN A 739 LYS A 890 GLY A 892 ASP A 895	NXU A1001 ( 4.2A) NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-3.5A) NXU A1001 (-3.4A) NXU A1001 (-3.1A)	0.71A	3q07B-4ra7A: 16.6	3q07B-4ra7A: 22.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SH8_A_CEDA1_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	6 / 12	SER A 682 SER A 737 ASN A 739 LYS A 890 THR A 891 GLY A 892	NXU A1001 (-1.3A) NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A)	0.37A	3sh8A-4ra7A: 16.3	3sh8A-4ra7A: 20.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SH8_B_CEDB1_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	6 / 12	SER A 682 LYS A 685 SER A 737 ASN A 739 LYS A 890 GLY A 892	NXU A1001 (-1.3A) NXU A1001 ( 4.2A) NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-3.5A) NXU A1001 (-3.4A)	0.42A	3sh8B-4ra7A: 16.0	3sh8B-4ra7A: 20.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3V3N_B_MIYB2001_1 (TETX2 PROTEIN)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	4 / 8	PHE A 684 GLY A 681 GLY A 746 MET A 778	None NXU A1001 ( 4.0A) None None	0.94A	3v3nB-4ra7A: undetectable	3v3nB-4ra7A: 20.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3V3N_C_MIYC2001_1 (TETX2 PROTEIN)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	4 / 8	PHE A 684 GLY A 681 GLY A 746 MET A 778	None NXU A1001 ( 4.0A) None None	0.94A	3v3nC-4ra7A: undetectable	3v3nC-4ra7A: 20.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4EUZ_A_MEMA401_1 (CARBAPENEM-HYDROLIZI NG BETA-LACTAMASE SFC-1)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	8 / 12	LYS A 685 SER A 737 ASN A 739 THR A 876 LYS A 890 THR A 891 GLY A 892 THR A 893	NXU A1001 ( 4.2A) NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-4.0A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A) NXU A1001 (-3.9A)	0.74A	4euzA-4ra7A: 15.7	4euzA-4ra7A: 21.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4FH2_A_0RNA303_1 (BETA-LACTAMASE SHV-1)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	5 / 10	SER A 737 ASN A 739 LYS A 890 THR A 891 GLY A 892	NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A)	0.53A	4fh2A-4ra7A: 17.2	4fh2A-4ra7A: 23.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N9K_A_CEDA301_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	6 / 12	SER A 682 SER A 737 ASN A 739 LYS A 890 THR A 891 GLY A 892	NXU A1001 (-1.3A) NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A)	0.35A	4n9kA-4ra7A: 16.2	4n9kA-4ra7A: 21.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4N9K_B_CEDB301_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	6 / 12	SER A 682 SER A 737 ASN A 739 LYS A 890 THR A 891 GLY A 892	NXU A1001 (-1.3A) NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A)	0.36A	4n9kB-4ra7A: 16.2	4n9kB-4ra7A: 21.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PM5_A_CE3A301_1 (BETA-LACTAMASE CTX-M-14)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	6 / 12	SER A 737 ASN A 739 THR A 876 LYS A 890 THR A 891 GLY A 892	NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-4.0A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A)	0.62A	4pm5A-4ra7A: 16.9	4pm5A-4ra7A: 22.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PM7_A_CE3A301_1 (BETA-LACTAMASE CTX-M-14)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	6 / 12	LYS A 685 SER A 737 ASN A 739 THR A 876 LYS A 890 GLY A 892	NXU A1001 ( 4.2A) NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-4.0A) NXU A1001 (-3.5A) NXU A1001 (-3.4A)	0.70A	4pm7A-4ra7A: 17.0	4pm7A-4ra7A: 22.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4PM9_A_CE3A301_1 (BETA-LACTAMASE CTX-M-14)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	6 / 12	SER A 737 ASN A 739 THR A 876 LYS A 890 THR A 891 GLY A 892	NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-4.0A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A)	0.61A	4pm9A-4ra7A: 16.8	4pm9A-4ra7A: 22.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5GHZ_A_CEDA301_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	6 / 11	SER A 682 SER A 737 ASN A 739 LYS A 890 THR A 891 GLY A 892	NXU A1001 (-1.3A) NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A)	0.36A	5ghzA-4ra7A: 16.0	5ghzA-4ra7A: 21.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5GHZ_B_CEDB301_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	6 / 10	SER A 682 SER A 737 ASN A 739 LYS A 890 THR A 891 GLY A 892	NXU A1001 (-1.3A) NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A)	0.37A	5ghzB-4ra7A: 16.1	5ghzB-4ra7A: 21.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5OJ0_A_9WTA801_0 (PENICILLIN-BINDING PROTEIN 2X)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	5 / 12	SER A 737 ASN A 739 THR A 876 GLY A 892 THR A 893	NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-4.0A) NXU A1001 (-3.4A) NXU A1001 (-3.9A)	1.03A	5oj0A-4ra7A: 31.1	5oj0A-4ra7A: 24.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_B_9F2B400_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	8 / 12	SER A 682 SER A 737 THR A 876 LYS A 890 THR A 891 GLY A 892 THR A 893 ASP A 895	NXU A1001 (-1.3A) NXU A1001 (-3.2A) NXU A1001 (-4.0A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A) NXU A1001 (-3.9A) NXU A1001 (-3.1A)	0.63A	6b5yB-4ra7A: 16.3	6b5yB-4ra7A: 13.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B5Y_D_9F2D400_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	8 / 12	SER A 682 SER A 737 THR A 876 LYS A 890 THR A 891 GLY A 892 THR A 893 ASP A 895	NXU A1001 (-1.3A) NXU A1001 (-3.2A) NXU A1001 (-4.0A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A) NXU A1001 (-3.9A) NXU A1001 (-3.1A)	0.67A	6b5yD-4ra7A: 16.2	6b5yD-4ra7A: 13.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_B_9F2B301_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	8 / 12	SER A 682 SER A 737 THR A 876 LYS A 890 THR A 891 GLY A 892 THR A 893 ASP A 895	NXU A1001 (-1.3A) NXU A1001 (-3.2A) NXU A1001 (-4.0A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A) NXU A1001 (-3.9A) NXU A1001 (-3.1A)	0.53A	6b68B-4ra7A: 16.3	6b68B-4ra7A: 13.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B68_D_9F2D400_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	7 / 12	SER A 682 SER A 737 THR A 876 LYS A 890 GLY A 892 THR A 893 ASP A 895	NXU A1001 (-1.3A) NXU A1001 (-3.2A) NXU A1001 (-4.0A) NXU A1001 (-3.5A) NXU A1001 (-3.4A) NXU A1001 (-3.9A) NXU A1001 (-3.1A)	0.58A	6b68D-4ra7A: 16.2	6b68D-4ra7A: 13.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_B_9F2B301_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	8 / 12	SER A 682 SER A 737 THR A 876 LYS A 890 THR A 891 GLY A 892 THR A 893 ASP A 895	NXU A1001 (-1.3A) NXU A1001 (-3.2A) NXU A1001 (-4.0A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A) NXU A1001 (-3.9A) NXU A1001 (-3.1A)	0.54A	6b69A-4ra7A: 15.8 6b69B-4ra7A: 16.1	6b69A-4ra7A: 13.23 6b69B-4ra7A: 13.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B69_D_9F2D301_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	7 / 12	SER A 682 SER A 737 THR A 876 LYS A 890 THR A 891 GLY A 892 THR A 893	NXU A1001 (-1.3A) NXU A1001 (-3.2A) NXU A1001 (-4.0A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A) NXU A1001 (-3.9A)	0.48A	6b69D-4ra7A: 16.0	6b69D-4ra7A: 13.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_B_9F2B301_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	8 / 12	SER A 682 SER A 737 THR A 876 LYS A 890 THR A 891 GLY A 892 THR A 893 ASP A 895	NXU A1001 (-1.3A) NXU A1001 (-3.2A) NXU A1001 (-4.0A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A) NXU A1001 (-3.9A) NXU A1001 (-3.1A)	0.55A	6b6aB-4ra7A: 16.4	6b6aB-4ra7A: 13.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6A_D_9F2D301_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	7 / 12	SER A 682 SER A 737 LYS A 890 THR A 891 GLY A 892 THR A 893 ASP A 895	NXU A1001 (-1.3A) NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A) NXU A1001 (-3.9A) NXU A1001 (-3.1A)	0.50A	6b6aD-4ra7A: 16.4	6b6aD-4ra7A: 13.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6C_A_9F2A301_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	6 / 12	SER A 682 SER A 737 LYS A 890 THR A 891 GLY A 892 THR A 893	NXU A1001 (-1.3A) NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A) NXU A1001 (-3.9A)	0.62A	6b6cA-4ra7A: 16.5	6b6cA-4ra7A: 13.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6D_A_9F2A302_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	7 / 12	SER A 682 SER A 737 THR A 876 LYS A 890 THR A 891 GLY A 892 THR A 893	NXU A1001 (-1.3A) NXU A1001 (-3.2A) NXU A1001 (-4.0A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A) NXU A1001 (-3.9A)	0.64A	6b6dA-4ra7A: 16.2	6b6dA-4ra7A: 13.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6E_A_9F2A302_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	7 / 12	SER A 682 SER A 737 THR A 876 LYS A 890 THR A 891 GLY A 892 THR A 893	NXU A1001 (-1.3A) NXU A1001 (-3.2A) NXU A1001 (-4.0A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A) NXU A1001 (-3.9A)	0.50A	6b6eA-4ra7A: 16.4	6b6eA-4ra7A: 13.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6F_A_9F2A301_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	6 / 12	SER A 682 SER A 737 LYS A 890 THR A 891 GLY A 892 ASP A 895	NXU A1001 (-1.3A) NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A) NXU A1001 (-3.1A)	0.64A	6b6fA-4ra7A: 16.3	6b6fA-4ra7A: 13.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6B6F_A_9F2A301_1 (BETA-LACTAMASE)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	6 / 12	SER A 682 SER A 737 LYS A 890 THR A 891 GLY A 892 THR A 893	NXU A1001 (-1.3A) NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-3.3A) NXU A1001 (-3.4A) NXU A1001 (-3.9A)	0.68A	6b6fA-4ra7A: 16.3	6b6fA-4ra7A: 13.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6C79_A_CE3A301_1 (BETA-LACTAMASE TOHO-1)	4ra7	PEPTIDOGLYCAN GLYCOSYLTRANSFERASE (Atopobium parvulum)	5 / 12	SER A 737 ASN A 739 THR A 876 LYS A 890 GLY A 892	NXU A1001 (-3.2A) NXU A1001 (-3.5A) NXU A1001 (-4.0A) NXU A1001 (-3.5A) NXU A1001 (-3.4A)	0.34A	6c79A-4ra7A: 16.5	6c79A-4ra7A: 12.22

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1GHM_A_CEDA1_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",6,"SER A 682;LYS A 685;SER A 737;ASN A 739;LYS A 890;GLY A 892","NXU A1001 (-1.3A);NXU A1001 ( 4.2A);NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-3.5A);NXU A1001 (-3.4A)","0.40A","1ghmA-4ra7A:15.3",null],["1GHM_A_CEDA1_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",6,"SER A 682;LYS A 685;TYR A 720;SER A 737;LYS A 890;GLY A 892","NXU A1001 (-1.3A);NXU A1001 ( 4.2A);NXU A1001 (-4.1A);NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-3.4A)","0.87A","1ghmA-4ra7A:15.3","1ghmA-4ra7A:20.39"],["1I2W_A_CFXA1300_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",7,"SER A 682;LYS A 685;SER A 737;ASN A 739;THR A 876;LYS A 890;GLY A 892","NXU A1001 (-1.3A);NXU A1001 ( 4.2A);NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-4.0A);NXU A1001 (-3.5A);NXU A1001 (-3.4A)","0.49A","1i2wA-4ra7A:15.7","1ghmA-4ra7A:20.39"],["1I2W_B_CFXB2300_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",6,"SER A 682;LYS A 685;SER A 737;ASN A 739;THR A 876;GLY A 892","NXU A1001 (-1.3A);NXU A1001 ( 4.2A);NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-4.0A);NXU A1001 (-3.4A)","0.54A","1i2wB-4ra7A:15.8","1i2wA-4ra7A:22.88"],["1YMX_A_CFXA1001_1","BETA-LACTAMASE CTX-M-9","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",8,"SER A 682;LYS A 685;SER A 737;ASN A 739;THR A 876;LYS A 890;GLY A 892;ASP A 895","NXU A1001 (-1.3A);NXU A1001 ( 4.2A);NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-4.0A);NXU A1001 (-3.5A);NXU A1001 (-3.4A);NXU A1001 (-3.1A)","0.70A","1ymxA-4ra7A:16.8","1i2wB-4ra7A:22.88"],["1YMX_B_CFXB1002_1","BETA-LACTAMASE CTX-M-9","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",7,"SER A 682;LYS A 685;SER A 737;ASN A 739;LYS A 890;GLY A 892;ASP A 895","NXU A1001 (-1.3A);NXU A1001 ( 4.2A);NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-3.5A);NXU A1001 (-3.4A);NXU A1001 (-3.1A)","0.61A","1ymxB-4ra7A:16.4","1ymxA-4ra7A:22.91"],["3HLW_A_CE3A301_1","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",6,"LYS A 685;SER A 737;ASN A 739;THR A 876;LYS A 890;GLY A 892","NXU A1001 ( 4.2A);NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-4.0A);NXU A1001 (-3.5A);NXU A1001 (-3.4A)","0.49A","3hlwA-4ra7A:16.8","1ymxB-4ra7A:22.91"],["3HLW_B_CE3B302_1","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",6,"SER A 737;ASN A 739;THR A 876;LYS A 890;THR A 891;GLY A 892","NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-4.0A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A)","0.38A","3hlwB-4ra7A:17.0","3hlwA-4ra7A:22.69"],["3HUO_A_PNNA300_0","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",6,"LYS A 685;ASN A 739;LYS A 890;THR A 891;GLY A 892;ASP A 895","NXU A1001 ( 4.2A);NXU A1001 (-3.5A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A);NXU A1001 (-3.1A)","0.57A","3huoA-4ra7A:16.8","3hlwB-4ra7A:22.69"],["3HUO_B_PNNB301_0","CTX-M-9 EXTENDED-SPECTRUM BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",5,"LYS A 685;ASN A 739;LYS A 890;GLY A 892;ASP A 895","NXU A1001 ( 4.2A);NXU A1001 (-3.5A);NXU A1001 (-3.5A);NXU A1001 (-3.4A);NXU A1001 (-3.1A)","0.62A","3huoB-4ra7A:16.7","3huoA-4ra7A:22.69"],["3NY4_A_SMXA308_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",8,"SER A 682;SER A 737;THR A 876;LYS A 890;THR A 891;GLY A 892;THR A 893;ASP A 895","NXU A1001 (-1.3A);NXU A1001 (-3.2A);NXU A1001 (-4.0A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A);NXU A1001 (-3.9A);NXU A1001 (-3.1A)","0.66A","3ny4A-4ra7A:16.3","3huoB-4ra7A:22.69"],["3Q07_A_WPPA300_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",6,"LYS A 685;SER A 737;ASN A 739;LYS A 890;GLY A 892;ASP A 895","NXU A1001 ( 4.2A);NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-3.5A);NXU A1001 (-3.4A);NXU A1001 (-3.1A)","0.58A","3q07A-4ra7A:16.6","3ny4A-4ra7A:23.80"],["3Q07_B_WPPB400_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",6,"LYS A 685;SER A 737;ASN A 739;LYS A 890;GLY A 892;ASP A 895","NXU A1001 ( 4.2A);NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-3.5A);NXU A1001 (-3.4A);NXU A1001 (-3.1A)","0.71A","3q07B-4ra7A:16.6","3q07A-4ra7A:22.69"],["3SH8_A_CEDA1_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",6,"SER A 682;SER A 737;ASN A 739;LYS A 890;THR A 891;GLY A 892","NXU A1001 (-1.3A);NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A)","0.37A","3sh8A-4ra7A:16.3","3q07B-4ra7A:22.69"],["3SH8_B_CEDB1_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",6,"SER A 682;LYS A 685;SER A 737;ASN A 739;LYS A 890;GLY A 892","NXU A1001 (-1.3A);NXU A1001 ( 4.2A);NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-3.5A);NXU A1001 (-3.4A)","0.42A","3sh8B-4ra7A:16.0","3sh8A-4ra7A:20.79"],["3V3N_B_MIYB2001_1","TETX2 PROTEIN","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",4,"PHE A 684;GLY A 681;GLY A 746;MET A 778","None;NXU A1001 ( 4.0A);None;None","0.94A","3v3nB-4ra7A:undetectable","3sh8B-4ra7A:20.79"],["3V3N_C_MIYC2001_1","TETX2 PROTEIN","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",4,"PHE A 684;GLY A 681;GLY A 746;MET A 778","None;NXU A1001 ( 4.0A);None;None","0.94A","3v3nC-4ra7A:undetectable","3v3nB-4ra7A:20.73"],["4EUZ_A_MEMA401_1","CARBAPENEM-HYDROLIZING BETA-LACTAMASE SFC-1","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",8,"LYS A 685;SER A 737;ASN A 739;THR A 876;LYS A 890;THR A 891;GLY A 892;THR A 893","NXU A1001 ( 4.2A);NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-4.0A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A);NXU A1001 (-3.9A)","0.74A","4euzA-4ra7A:15.7","3v3nC-4ra7A:20.73"],["4FH2_A_0RNA303_1","BETA-LACTAMASE SHV-1","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",5,"SER A 737;ASN A 739;LYS A 890;THR A 891;GLY A 892","NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A)","0.53A","4fh2A-4ra7A:17.2","4euzA-4ra7A:21.83"],["4N9K_A_CEDA301_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",6,"SER A 682;SER A 737;ASN A 739;LYS A 890;THR A 891;GLY A 892","NXU A1001 (-1.3A);NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A)","0.35A","4n9kA-4ra7A:16.2","4fh2A-4ra7A:23.74"],["4N9K_B_CEDB301_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",6,"SER A 682;SER A 737;ASN A 739;LYS A 890;THR A 891;GLY A 892","NXU A1001 (-1.3A);NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A)","0.36A","4n9kB-4ra7A:16.2","4n9kA-4ra7A:21.01"],["4PM5_A_CE3A301_1","BETA-LACTAMASE CTX-M-14","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",6,"SER A 737;ASN A 739;THR A 876;LYS A 890;THR A 891;GLY A 892","NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-4.0A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A)","0.62A","4pm5A-4ra7A:16.9","4n9kB-4ra7A:21.01"],["4PM7_A_CE3A301_1","BETA-LACTAMASE CTX-M-14","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",6,"LYS A 685;SER A 737;ASN A 739;THR A 876;LYS A 890;GLY A 892","NXU A1001 ( 4.2A);NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-4.0A);NXU A1001 (-3.5A);NXU A1001 (-3.4A)","0.70A","4pm7A-4ra7A:17.0","4pm5A-4ra7A:22.47"],["4PM9_A_CE3A301_1","BETA-LACTAMASE CTX-M-14","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",6,"SER A 737;ASN A 739;THR A 876;LYS A 890;THR A 891;GLY A 892","NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-4.0A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A)","0.61A","4pm9A-4ra7A:16.8","4pm7A-4ra7A:22.39"],["5GHZ_A_CEDA301_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",6,"SER A 682;SER A 737;ASN A 739;LYS A 890;THR A 891;GLY A 892","NXU A1001 (-1.3A);NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A)","0.36A","5ghzA-4ra7A:16.0","4pm9A-4ra7A:22.37"],["5GHZ_B_CEDB301_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",6,"SER A 682;SER A 737;ASN A 739;LYS A 890;THR A 891;GLY A 892","NXU A1001 (-1.3A);NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A)","0.37A","5ghzB-4ra7A:16.1","5ghzA-4ra7A:21.01"],["5OJ0_A_9WTA801_0","PENICILLIN-BINDING PROTEIN 2X","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",5,"SER A 737;ASN A 739;THR A 876;GLY A 892;THR A 893","NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-4.0A);NXU A1001 (-3.4A);NXU A1001 (-3.9A)","1.03A","5oj0A-4ra7A:31.1","5ghzB-4ra7A:21.01"],["6B5Y_B_9F2B400_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",8,"SER A 682;SER A 737;THR A 876;LYS A 890;THR A 891;GLY A 892;THR A 893;ASP A 895","NXU A1001 (-1.3A);NXU A1001 (-3.2A);NXU A1001 (-4.0A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A);NXU A1001 (-3.9A);NXU A1001 (-3.1A)","0.63A","6b5yB-4ra7A:16.3","5oj0A-4ra7A:24.10"],["6B5Y_D_9F2D400_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",8,"SER A 682;SER A 737;THR A 876;LYS A 890;THR A 891;GLY A 892;THR A 893;ASP A 895","NXU A1001 (-1.3A);NXU A1001 (-3.2A);NXU A1001 (-4.0A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A);NXU A1001 (-3.9A);NXU A1001 (-3.1A)","0.67A","6b5yD-4ra7A:16.2","6b5yB-4ra7A:13.23"],["6B68_B_9F2B301_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",8,"SER A 682;SER A 737;THR A 876;LYS A 890;THR A 891;GLY A 892;THR A 893;ASP A 895","NXU A1001 (-1.3A);NXU A1001 (-3.2A);NXU A1001 (-4.0A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A);NXU A1001 (-3.9A);NXU A1001 (-3.1A)","0.53A","6b68B-4ra7A:16.3","6b5yD-4ra7A:13.23"],["6B68_D_9F2D400_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",7,"SER A 682;SER A 737;THR A 876;LYS A 890;GLY A 892;THR A 893;ASP A 895","NXU A1001 (-1.3A);NXU A1001 (-3.2A);NXU A1001 (-4.0A);NXU A1001 (-3.5A);NXU A1001 (-3.4A);NXU A1001 (-3.9A);NXU A1001 (-3.1A)","0.58A","6b68D-4ra7A:16.2","6b68B-4ra7A:13.23"],["6B69_B_9F2B301_1","BETA-LACTAMASE;BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",8,"SER A 682;SER A 737;THR A 876;LYS A 890;THR A 891;GLY A 892;THR A 893;ASP A 895","NXU A1001 (-1.3A);NXU A1001 (-3.2A);NXU A1001 (-4.0A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A);NXU A1001 (-3.9A);NXU A1001 (-3.1A)","0.54A","6b69A-4ra7A:15.8;6b69B-4ra7A:16.1","6b68D-4ra7A:13.23"],["6B69_D_9F2D301_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",7,"SER A 682;SER A 737;THR A 876;LYS A 890;THR A 891;GLY A 892;THR A 893","NXU A1001 (-1.3A);NXU A1001 (-3.2A);NXU A1001 (-4.0A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A);NXU A1001 (-3.9A)","0.48A","6b69D-4ra7A:16.0","6b69A-4ra7A:13.23;6b69B-4ra7A:13.23"],["6B6A_B_9F2B301_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",8,"SER A 682;SER A 737;THR A 876;LYS A 890;THR A 891;GLY A 892;THR A 893;ASP A 895","NXU A1001 (-1.3A);NXU A1001 (-3.2A);NXU A1001 (-4.0A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A);NXU A1001 (-3.9A);NXU A1001 (-3.1A)","0.55A","6b6aB-4ra7A:16.4","6b69D-4ra7A:13.23"],["6B6A_D_9F2D301_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",7,"SER A 682;SER A 737;LYS A 890;THR A 891;GLY A 892;THR A 893;ASP A 895","NXU A1001 (-1.3A);NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A);NXU A1001 (-3.9A);NXU A1001 (-3.1A)","0.50A","6b6aD-4ra7A:16.4","6b6aB-4ra7A:13.23"],["6B6C_A_9F2A301_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",6,"SER A 682;SER A 737;LYS A 890;THR A 891;GLY A 892;THR A 893","NXU A1001 (-1.3A);NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A);NXU A1001 (-3.9A)","0.62A","6b6cA-4ra7A:16.5","6b6aD-4ra7A:13.23"],["6B6D_A_9F2A302_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",7,"SER A 682;SER A 737;THR A 876;LYS A 890;THR A 891;GLY A 892;THR A 893","NXU A1001 (-1.3A);NXU A1001 (-3.2A);NXU A1001 (-4.0A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A);NXU A1001 (-3.9A)","0.64A","6b6dA-4ra7A:16.2","6b6cA-4ra7A:13.23"],["6B6E_A_9F2A302_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",7,"SER A 682;SER A 737;THR A 876;LYS A 890;THR A 891;GLY A 892;THR A 893","NXU A1001 (-1.3A);NXU A1001 (-3.2A);NXU A1001 (-4.0A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A);NXU A1001 (-3.9A)","0.50A","6b6eA-4ra7A:16.4","6b6dA-4ra7A:13.23"],["6B6F_A_9F2A301_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",6,"SER A 682;SER A 737;LYS A 890;THR A 891;GLY A 892;ASP A 895","NXU A1001 (-1.3A);NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A);NXU A1001 (-3.1A)","0.64A","6b6fA-4ra7A:16.3","6b6eA-4ra7A:13.23"],["6B6F_A_9F2A301_1","BETA-LACTAMASE","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",6,"SER A 682;SER A 737;LYS A 890;THR A 891;GLY A 892;THR A 893","NXU A1001 (-1.3A);NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-3.3A);NXU A1001 (-3.4A);NXU A1001 (-3.9A)","0.68A","6b6fA-4ra7A:16.3","6b6fA-4ra7A:13.23"],["6C79_A_CE3A301_1","BETA-LACTAMASE TOHO-1","4ra7","PEPTIDOGLYCAN GLYCOSYLTRANSFERASE","Atopobium parvulum",5,"SER A 737;ASN A 739;THR A 876;LYS A 890;GLY A 892","NXU A1001 (-3.2A);NXU A1001 (-3.5A);NXU A1001 (-4.0A);NXU A1001 (-3.5A);NXU A1001 (-3.4A)","0.34A","6c79A-4ra7A:16.5","6b6fA-4ra7A:13.23"]]